Last reviewed · How we verify
NCT02698085
Diacutaneous Fibrolysis on Carpal Tunnel Syndrome
NA trial testing Actual Diacutaneous Fibrolysis in Carpal Tunnel Syndrome in 60 participants. Completed in 10 October 2016.
1 September 2016
Quick facts
| Lead sponsor | Universidad de Zaragoza |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 1 April 2016 |
| Primary completion | 1 September 2016 |
| Estimated completion | 10 October 2016 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Actual Diacutaneous Fibrolysis
- Sham Diacutaneous Fibrolysis
Conditions studied
- Carpal Tunnel Syndrome — all drugs for Carpal Tunnel Syndrome →
Sponsor
Universidad de Zaragoza — full company profile →
Who can join
Adults 18 to 65, any sex, with Carpal Tunnel Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Diacutaneous Fibrolysis is a manual method of treatment, addressed to mechanical pain of the neuromusculoskeletal system. In the clinical practice a favorable effect is observed in patients with carpal tunnel syndrome, but there is no published studies evaluating the results os this technique. The objective of this trial is to evaluate if Diacutaneous Fibrolysis is more effective in symptoms, function, grip, mechanosensitivity and neural conduction velocity compared to a placebo. For this purpose the investigators conduct a randomized controlled trial double-blind (patient and examiner). The investigators included patients diagnosed of carpal tunnel syndrome (low to moderate intensity) with a neurophysiological test. Patients included are randomized into 2 groups one receive Diacutaneous Fibrolysis and the other placebo. Both groups receive 5 treatment sessions. The variables are measured at the beginning and end of treatment. And also some variables are measured before and after each session. Patients who participated in placebo group, when the intervention finish the investigators will be given the opportunity to receive the actual technique
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02698085
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Carpal Tunnel Syndrome
Currently open trials in the same condition.
- NCT07312123 — A Study to See Whether Taking a Mix of Vitamins Can Help Adults Recover Better After Surgery for Carpal Tunnel Syndrome · NA · recruiting
- NCT07334964 — Ultrasound-Guided Carpal Tunnel Infiltration: Comparison Between the Manual Method and a Robot-Assisted Method · NA · recruiting
- NCT07414069 — High-Intensity Laser Therapy in Carpal Tunnel Syndrome: Clinical, Sonographic, and Electrophysiological Outcomes · NA · recruiting
- NCT07114913 — Symptom Distribution and Pain Sensitization in Carpal Tunnel Syndrome · recruiting
- NCT06905769 — Effects of Aquatic Therapy Versus Neuro-dynamic Technique for the Treatment of Carpal Tunnel Syndrome Patient · NA · active not recruiting
Other Universidad de Zaragoza trials
Trials by the same sponsor.
- NCT07497217 — Change in ATOR Screening Test Scores Over 12 Weeks · NA · recruiting
- NCT07395830 — Effects of a Multisensory VR Experience on Stress and User Experience · NA · not yet recruiting
- NCT07398040 — Clinical Impact of an Anti-Inflammatory Diet in Anxiety and Depression With AI · NA · enrolling by invitation
- NCT07066696 — Mindfulness and Compassion Program for the Improvement of Emotional and Behavioral Problems, Academic Performance and Sc · NA · not yet recruiting
- NCT07086209 — Optimizing Hamstring Rehabilitation With Amino Acids · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02698085 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad de Zaragoza
- Last refreshed: 21 November 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02698085.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing